MobiHealth News April 12, 2024
Trevor Dermody

The feature provides vibrotactile stimulation when a patient is experiencing freezing of gait, a common symptom of Parkinson’s disease.

Turkey-based digital health startup h2o therapeutics announced its new Apple Watch-enabled freezing of gait-cuing feature, dubbed Foggy, designed for Parkinson’s Disease patients has received FDA listing as a Class II medical device and is available via prescription.

According to the Parkinson’s Foundation, freezing of gait is a symptom of Parkinson’s Disease in which a patient experiences a temporary, involuntary inability to move. Freezing may also affect a person’s speech or other parts of the body.

h2o therapeutics is a company that deploys augmented reality, AI and mobile-based digital therapeutics. The company also offers an early-detection COVID-19 smartwatch system named Covie.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, FDA, Govt Agencies, Medical Devices, Technology
GE HealthCare Expands Cardiac AI Coaching to Hand-Held Ultrasound Scanner
Orthobond Receives FDA De Novo Approval for Antibacterial Technology
The Top 25 Medical Device Executives of 2024
New regulations to help turn tide on health care cyberattacks
Digital Health Intelligence Market Analysis: Medical Device Cyber Security

Share This Article